Skip to main content

Company News

February 28, 2024

The Rise of Multi-Drug Resistant Candidiasis in COVID-19 Patients

Data suggests that since the onset of the COVID-19 pandemic, there has been an increased prevalence of antimicrobial resistant infections and increases in healthcare-associated infections (HAIs). A recent study shows an alarming incidence of multidrug-resistant candidiasis in COVID-19 patients, which carries high morbidity and mortality rates. With this increasing prevalence of resistant infections, the utilization of surveillance tools such as whole genome sequencing (WGS) are critical in preventing the spread of these infections.
  • December 18, 2023

    CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies

    CATTI, Canadian Advanced Therapies Training Institute, and bioMérieux Canada are combining their respective strengths to enhance the training of the workforce in advanced therapies and the production of quality control solutions (for the pharmaceutical industries).
  • December 13, 2023

    bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America

    In 2020, bioMérieux launched an innovative educational program in Latin America dedicated to healthcare professionals to strenghten their understanding and practice of microbiology.
  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
  • April 20, 2023

    bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)

    bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.

Follow us on Socials for more news!